ArticleFrontiers in oncology2025

Improved survival with phosphodiesterase-5 inhibitor use in men with male-predominant cancers: real-world large database study.

Daniel Uralov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.